- Overview
- Key stats
- Stock price
- Financial performance
- Growth
- Valuations
- Efficiency
- Dividends
- Financial health
- Stocks
- Healthcare
- NASDAQ: INBX
Price (delayed)
$12.15
Market cap
$175.88M
P/E Ratio
0.11
Dividend/share
N/A
EPS
$114.01
Enterprise value
$31.33M
Highlights
The debt has plunged by 96% YoY
The company's net income rose by 2.8% QoQ
Inhibrx Biosciences's gross profit has plunged by 89% YoY and by 88% from the previous quarter
The revenue has shrunk by 89% YoY and by 88% QoQ
Key stats
What are the main financial stats of INBX
MarketValuationsEarnings
Shares outstanding
14.48M
Market cap
$175.88M
Enterprise value
$31.33M
Price to earnings (P/E)
0.11
Price to book (P/B)
1.32
Price to sales (P/S)
899.22
EV/EBIT
0.02
EV/EBITDA
0.02
EV/Sales
156.67
Revenue
$200,000
Gross profit
$200,000
Operating income
-$331.45M
Net income
$1.69B
EBIT
$1.7B
EBITDA
$1.71B
Free cash flow
-$197.01M
Per shareBalance sheetLiquidity
EPS
$114.01
EPS diluted
$112.62
Free cash flow per share
-$13.31
Book value per share
$9.23
Revenue per share
$0.01
TBVPS
$12.21
Total assets
$180.77M
Total liabilities
$47.18M
Debt
$8.05M
Equity
$133.58M
Working capital
$119.67M
Debt to equity
0.06
Current ratio
3.94
Quick ratio
3.76
Net debt/EBITDA
-0.08
MarginsEfficiencyDividend
EBITDA margin
852,623.5%
Gross margin
100%
Net margin
843,786%
Operating margin
-165,724%
Return on assets
710.3%
Return on equity
1,243.2%
Return on invested capital
4,559%
Return on capital employed
1,214.7%
Return on sales
850,532.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INBX stock price
How has the Inhibrx Biosciences stock price performed over time
Intraday
-1.38%
1 week
-0.9%
1 month
-13.83%
1 year
N/A
YTD
-21.1%
QTD
-13.15%
Financial performance
How have Inhibrx Biosciences's revenue and profit performed over time
Revenue
$200,000
Gross profit
$200,000
Operating income
-$331.45M
Net income
$1.69B
Gross margin
100%
Net margin
843,786%
INBX financials
Inhibrx Biosciences's gross profit has plunged by 89% YoY and by 88% from the previous quarter
The revenue has shrunk by 89% YoY and by 88% QoQ
INBX's operating income has shrunk by 51% YoY but it is up by 10% QoQ
The company's net income rose by 2.8% QoQ
Price vs fundamentals
Earnings waterfall
Growth
What is Inhibrx Biosciences's growth rate over time
INBX growth chart
Valuation
What is Inhibrx Biosciences stock price valuation
P/E
0.11
P/B
1.32
P/S
899.22
EV/EBIT
0.02
EV/EBITDA
0.02
EV/Sales
156.67
Valuation vs average
Price to earnings (P/E)
Price to book (P/B)
Inhibrx Biosciences's equity has decreased by 25% QoQ
Price to sales (P/S)
The revenue has shrunk by 89% YoY and by 88% QoQ
Efficiency
How efficient is Inhibrx Biosciences business performance
Inhibrx Biosciences's ROIC has soared by 131% from the previous quarter
The company's return on assets rose by 17% QoQ
The ROE has decreased by 14% from the previous quarter
Dividends
What is INBX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INBX.
Financial health
How did Inhibrx Biosciences financials performed over time
Assets vs liabilities
The total liabilities has plunged by 82% YoY but it has grown by 7% from the previous quarter
Inhibrx Biosciences's total assets has decreased by 41% YoY and by 19% QoQ
Debt vs equity
The debt is 94% less than the equity
The debt to equity has plunged by 99% YoY
The debt has plunged by 96% YoY
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.